Atrial Natriuretic Peptide (ANP), rat: High-Purity Peptide for Cardiovascular Research

Executive Summary: Atrial Natriuretic Peptide (ANP), rat, is a 28-amino acid peptide hormone with the molecular formula C₄₉H₈₄N₂₀O₁₅S and a molecular weight of 1225.38 Da, synthesized and secreted by atrial myocytes in response to atrial distension and neurohormonal stimuli (APExBIO ANP, A1009). ANP acts as a potent vasodilator, regulating blood pressure and promoting natriuresis in rodents and humans (Angiotensin-II.com). The product from APExBIO features >95.9% purity, confirmed by HPLC and mass spectrometry, and is optimized for experimental reproducibility. ANP is critical for research in cardiovascular and renal physiology, as well as adipose tissue metabolism regulation (BNP1-32.com). It is soluble at ≥122.5 mg/mL in DMSO and ≥43.5 mg/mL in water, and must be stored at -20°C for stability.

Biological Rationale

Atrial Natriuretic Peptide (ANP) is an endogenous peptide hormone produced primarily by cardiac atrial myocytes. Its secretion is triggered by increased atrial stretch, elevated blood volume, angiotensin II, endothelin, and sympathetic nervous system activation (NCBI Bookshelf). ANP plays a central role in the maintenance of body fluid, sodium, and potassium homeostasis. It acts by promoting natriuresis (the excretion of sodium in urine), diuresis (water excretion), and vasodilation, thereby reducing blood volume and systemic vascular resistance. This concerted effect lowers blood pressure and reduces cardiac workload, making ANP an important biomolecule for studies in cardiovascular and renal physiology (Endothelin-1.com). This article extends previous reviews by providing detailed experimental parameters and clarifying storage/handling for maximal peptide integrity.

Mechanism of Action of Atrial Natriuretic Peptide (ANP), rat

ANP binds to natriuretic peptide receptor-A (NPR-A), a guanylyl cyclase-coupled receptor predominantly expressed on vascular smooth muscle cells, renal tubules, and adipocytes. Upon receptor activation, cyclic guanosine monophosphate (cGMP) levels increase, initiating downstream signaling cascades leading to:

• Relaxation of vascular smooth muscle, causing vasodilation and decreased systemic blood pressure.
• Inhibition of sodium reabsorption in renal collecting ducts, enhancing natriuresis and diuresis.
• Suppression of the renin-angiotensin-aldosterone system (RAAS), reducing fluid retention.
• Regulation of adipose tissue metabolism, including modulation of lipolysis and adiponectin signaling (Zhang et al., 2022).

APExBIO's ANP peptide (A1009) is designed for high solubility and purity, ensuring reliable activation of these physiological pathways in experimental models (Angiotensin-II.com). This article updates the mechanistic overview by emphasizing validated storage and solubility parameters for consistent results.

Evidence & Benchmarks

• ANP reduces blood pressure in vivo by 10–20 mmHg within minutes of administration in rat models (https://www.ncbi.nlm.nih.gov/books/NBK459455/).
• ANP administration significantly increases urinary sodium excretion within 30–60 minutes in both acute and chronic studies (https://bnp1-32.com/index.php?g=Wap&m=Article&a=detail&id=15902).
• Peptide purity >95.9% by HPLC and mass spectrometry is confirmed for APExBIO's A1009 product, ensuring experimental reproducibility (Angiotensin-II.com).
• ANP modulates adipose tissue metabolism by enhancing adiponectin signaling, which can attenuate neuroinflammation and oxidative stress (Zhang et al., 2022, DOI).
• Solubility in DMSO (≥122.5 mg/mL) and water (≥43.5 mg/mL) enables high-precision dosing for in vitro and in vivo studies (Atrial Natriuretic Peptide (ANP), rat).

Applications, Limits & Misconceptions

ANP is widely used in:

• Cardiovascular research—studying mechanisms of blood pressure regulation and vasodilation.
• Renal physiology research—elucidating natriuresis and diuresis mechanisms.
• Metabolic studies—investigating the cross-talk between adipose tissue and cardiovascular homeostasis, including links to adiponectin signaling and neuroinflammation (Zhang et al., 2022).
• Translational models for preclinical drug development targeting hypertension, heart failure, and metabolic syndrome.

Compared to prior reviews that focus on neuroimmune mechanisms, this article provides more granular detail on peptide solubility, storage, and purity data for experimental design.

Common Pitfalls or Misconceptions

• Misuse of storage conditions: ANP degrades rapidly at room temperature; always store at -20°C and minimize freeze-thaw cycles (APExBIO ANP).
• Solubility errors: ANP is insoluble in ethanol; dissolving in DMSO or water is essential for activity assessment.
• Species extrapolation: Data from rat studies may not directly translate to human physiology; reference controls are required.
• Neglecting batch purity: Using unverified sources or lower-purity peptides can lead to inconsistent results.
• Overinterpreting metabolic effects: ANP's direct role in neurocognitive disorders is not established; effects on adiponectin and neuroinflammation remain under investigation (hypothesis) (Zhang et al., 2022).

Workflow Integration & Parameters

For optimal results with Atrial Natriuretic Peptide (ANP), rat (APExBIO, A1009):

• Dissolve peptide at ≥122.5 mg/mL in DMSO or ≥43.5 mg/mL in water; avoid ethanol as a solvent.
• Aliquot and store at -20°C; avoid repeated freeze-thaw cycles.
• Use freshly prepared solutions; do not store diluted peptide long-term.
• Verify peptide purity by HPLC/mass spectrometry documentation before use.
• For in vivo experiments, follow established dosing regimens (e.g., 10–100 μg/kg, route and frequency as published).
• Include appropriate positive and negative controls—such as synthetic vehicle, scrambled peptide, or NPR-A antagonist.

This article clarifies and extends the best-practice experimental workflows outlined in Angiotensin-II.com by providing explicit solubility and storage details for reproducibility.

Conclusion & Outlook

Rat atrial natriuretic peptide (ANP) remains a validated, high-purity tool for dissecting cardiovascular, renal, and metabolic regulation. The APExBIO A1009 product ensures experimental reproducibility and reliability via stringent quality controls. Future research will further elucidate ANP's role in neuroimmune crosstalk and metabolic disease modulation, leveraging its robust biophysical and physiological properties. For further details, consult the primary product page (Atrial Natriuretic Peptide (ANP), rat).